The AP (12/4) reports that the Food and Drug
Administration announced Monday that it will
"collaborate with medical device manufacturers on a public-private
partnership." The FDA "says it hopes to offer guidance" to the
Medical Device Innovation Consortium (MDIC), which was "created by
LifeScience Alley, a Minnesota-based industry group" to streamline the
"design and testing of medical devices." The AP suggests that the
agency's decision to play a role in the new consortium is a response to
"criticism from industry and Capitol Hill" about its "overly
burdensome review process."
Reuters (12/4, Kelly) adds that the goal of
the nonprofit MDIC is to improve the methods used during the medical-device
development process so more products can reach the market faster. Industry
members involved in the MDIC include representatives from Abiomed, Becton Dickinson,
Boston Scientific, Cyberonics and Medtronic. Reuters quotes FDA Commissioner
Dr. Margaret Hamburg as saying, during a press teleconference, that the MDIC
"is going to represent a model that will be watched carefully, will be
replicated. I know there will be real advances and new approaches that will
emerge from it."
The Minneapolis Star Tribune (12/4, Walsh) adds
that Dr. Hamburg noted that many companies "don't have the research
budgets to find more effective ways of testing their products." She said
the MDIC would "pull information and ideas from industry, government and
academia" to ensure "we're applying the best science to the task and
bringing together the best minds." The consortium will be "governed
by a national board of directors, including industry executives and government
leaders."
According to CQ (12/4, Adams, Subscription Publication),
the "partnership will be funded largely by device companies, although the
FDA and the Centers for Medicare and Medicaid Services may contribute funding
later." Dr. Hamburg called the consortium the "first public-private
partnership of its kind in the medical device area" and cited
"interest from a wide variety of groups, including members of Congress, for
the agency's ability to move forward with the initiative." The MDIC will
"invest in projects" that could reduce the time and costs involved in
medical-device development. The alliance has not yet decided on "specific
projects" to fund but they could "include investments in research to
improve computer models or other tools that can test the effects of potential
devices." The MDIC is planning to hold its "initial meeting in the
first quarter of 2013."
Modern Healthcare (12/4, Daly, Subscription
Publication) adds that the FDA's "support for the initiative may extend to
its staff collaborating on partnership-supported research." The FDA's
Center for Devices and Radiological Health Director Dr. Jeffrey Shuren said,
"By sharing and leveraging resources, MDIC may help industry to be better
equipped to bring safe and effective medical devices to market more quickly and
at a lower cost."
The Minneapolis-St. Paul (MN) Business Journal
(12/4, Grayson, Subscription Publication) reports that the MDIC "will be
led on an interim basis" by Maura Donovan, who recently served as
"vice president of therapy research and development" at Fridley,
Minnesota-based Medtronic Inc.
Medscape (12/4, Lowes) says that in addition
to the FDA, the CMS and the medical device firms, the MDIC's founding members
include LifeScience Alley, the Pew Charitable Trust and the National
Organization for Rare Disorders. HealthDay (12/4, Preidt) also covers the new
public-private partnership.
DIA Daily is a digest of the most important news selected from thousands of sources by the editors of BulletinHealthcare. The presence of content or advertising does not endorse, nor imply endorsement of, any products or services by the Drug Information Association. Neither BulletinHealthcare nor the Drug Information Association is liable for the use of or reliance on any information contained in this briefing.
Drug Information Association | 800 Enterprise Road, Suite 200 | Horsham, PA 19044
Copyright © 2012 by BulletinHealthcare| 11190 Sunrise Valley Drive, Suite 130 | Reston, VA 20191
No comments:
Post a Comment